Quantification of neurofilament light and glial fibrillary acidic protein in finger-prick blood
Magdalena Kolanko(UK Dementia Research Institute), Neil Graham(Hammersmith Hospital), Hanna Huber(University Hospital Bonn), Joel Simrén(University of Gothenburg), Kaj Blennow(Sahlgrenska University Hospital), Paresh Malhotra(Imperial College London), Ramin Nilforooshan(University of Surrey), David Sharp(Albert Einstein College of Medicine), Michael David(UK Dementia Research Institute), Laia Montoliu‐Gaya(Sahlgrenska University Hospital), Henrik Zetterberg(University of Wisconsin–Madison), Nicholas J. Ashton(King's College London)
Cited by 7
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k